CARDIOMYOPATHY, HYPERTROPHIC
Clinical trials for CARDIOMYOPATHY, HYPERTROPHIC explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY, HYPERTROPHIC trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, HYPERTROPHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart procedure may beat drugs for lethal rhythm disorder
Disease control OngoingThis study compares two treatments for ventricular tachycardia (VT), a fast, dangerous heart rhythm, in people with structural heart disease. One treatment is a procedure called catheter ablation that destroys the tiny heart areas causing the problem. The other is standard anti-a…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: NA • Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
New hope for teens with rare heart disease: drug trial aims to ease symptoms
Disease control OngoingThis study tests a drug called mavacamten in 44 teenagers (ages 12 to under 18) who have a condition where the heart muscle is too thick and blocks blood flow. The goal is to see if the drug can reduce the blockage and improve symptoms like shortness of breath or chest pain. Part…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Heart drug mavacamten shows promise in thickened heart muscle study
Disease control OngoingThis study looks at whether the drug mavacamten can improve heart structure in 63 adults with a condition that makes the heart muscle too thick and blocks blood flow. Participants take the medication and have heart scans to measure changes. The goal is to see if the drug can redu…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 15, 2026 11:53 UTC